通过跨三国分布式学习构建并验证NSCLC生存预测模型
研究基于荷兰与美国的698例接受根治性放化疗或单纯放疗的非小细胞肺癌(NSCLC)患者临床数据,采用贝叶斯网络进行分布式学习,构建2年治疗后生存预测模型,并在英国196例患者中外部验证。最终模型纳入T和N分期、年龄、体能状态与肿瘤总剂量,外部验证AUC为0.66,5折交叉验证AUC为0.62;仅用T和N分期的模型验证AUC为0.47,显著差于本模型(P<.001)。集中式与分布式学习所得模型在验证集上的判别性能相似(P=.26)。
要点
- 模型纳入T/N分期、年龄、体能状态和肿瘤总剂量预测NSCLC放疗后2年生存。
- 外部验证AUC为0.66,5折交叉验证AUC为0.62。
- 分布式学习与集中式学习模型判别性能相似(P=.26)。
核心结论
- 基于多机构联邦数据库的分布式学习可构建NSCLC放疗后2年生存预测模型,且避免诸多数据共享障碍。
研究设计与样本
- 多中心回顾性数据研究;训练数据698例(Maastro 559例、Michigan 139例),外部验证196例(The Christie)。
- 采用适配分布式学习的贝叶斯网络模型,终点为治疗后2年生存。
主要发现
- 最终模型变量为T和N分期、年龄、体能状态、肿瘤总剂量;外部验证AUC 0.66,5折交叉验证AUC 0.62。
- 仅基于T和N分期的模型验证AUC 0.47,显著差于本模型(P<.001)。
- 集中式与分布式学习对条件概率表概率影响较小(0.6%),验证集判别性能相似(P=.26)。
关键数值与推荐
- 外部验证集AUC 0.66;5折交叉验证AUC 0.62;T/N分期模型验证AUC 0.47(P<.001)。
- 集中式与分布式学习条件概率表概率差异0.6%,验证集判别性能比较P=.26。
临床怎么用
- 该模型基于常规临床变量预测NSCLC根治性放疗后2年生存,模型已公开于www.predictcancer.org,可供临床参考;分布式学习可支持多机构联合建模而不直接共享数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Tools for survival prediction for non-small cell lung cancer (NSCLC) patients treated with chemoradiation or radiation therapy are of limited quality. In this work, we developed a predictive model of survival at 2 years. The model is based on a large volume of historical patient data and serves as a proof of concept to demonstrate the distributed learning approach. METHODS AND MATERIALS: Clinical data from 698 lung cancer patients, treated with curative intent with chemoradiation or radiation therapy alone, were collected and stored at 2 different cancer institutes (559 patients at Maastro clinic (Netherlands) and 139 at Michigan university [United States]). The model was further validated on 196 patients originating from The Christie (United Kingdon). A Bayesian network model was adapted for distributed learning (the animation can be viewed at https://www.youtube.com/watch?v=ZDJFOxpwqEA). Two-year posttreatment survival was chosen as the endpoint. The Maastro clinic cohort data are publicly available at https://www.cancerdata.org/publication/developing-and-validating-survival-prediction-model-nsclc-patients-through-distributed, and the developed models can be found at www.predictcancer.org. RESULTS: Variables included in the final model were T and N category, age, performance status, and total tumor dose. The model has an area under the curve (AUC) of 0.66 on the external validation set and an AUC of 0.62 on a 5-fold cross validation. A model based on the T and N category performed with an AUC of 0.47 on the validation set, significantly worse than our model (P<.001). Learning the model in a centralized or distributed fashion yields a minor difference on the probabilities of the conditional probability tables (0.6%); the discriminative performance of the models on the validation set is similar (P=.26). CONCLUSIONS: Distributed learning from federated databases allows learning of predictive models on data originating from multiple institutions while avoiding many of the data-sharing barriers. We believe that distributed learning is the future of sharing data in health care.
引用
- Jochems A, Deist TM, El Naqa I, et al. Developing and Validating a Survival Prediction Model for NSCLC Patients Through Distributed Learning Across 3 Countries. Int J Radiat Oncol Biol Phys. 2017. PMID: 28871984. doi:10.1016/j.ijrobp.2017.04.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。